Hamburg Gives Rallying Cry For FDA Power In Her Public Farewell
This article was originally published in The Tan Sheet
Executive Summary
The outgoing commissioner gives forceful defense of the agency’s regulatory authority and warns that lowering drug approval standards would damage patients and industry.